News

Proteomics International Laboratories Ltd OxiDx Platform Technology Secures Patent in Japan – The West Australian

Proteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has been granted a breakthrough patent in Japan for its finger prick technology that determines oxidative stress protein biomarkers implicated in chronic diseases.

The patent, which is valid to 2039, paves the way for the company to commercialise its novel technology in high-performance athletes, the horse-racing industry and in clinical trials.

Proteomics says it is the first of what will be a family of patents it will apply for in all major jurisdictions. Once granted, the patents will extend the global reach and lifespan of its innovative technology.

Article: Proteomics International Laboratories Ltd OxiDx Platform Technology Secures Patent in Japan

Subscribe

  • This field is for validation purposes and should be left unchanged.